In this issue:
NCCN Breast Cancer guideline refresh (v1.2026, January 2026)
St Gallen BC consensus: Individualising therapy for early BC
ESMO Living Guideline: mBC—updated systemic treatment recommendations
PBS co-payment reduction
Trazimera shortage listing
TGA: Section 19A import/supply approval for Paclitaxel during shortage
NZ: Pharmac funds SC Phesgo® for HER2+ mBC
FDA late-2025 oncology approvals: ADC label expansions
Registry-listed study of contrast-enhanced mammography
ESMO Breast Cancer 2026: Registration open (early deadline 26 February 2026)
ASCO Annual Meeting 2026: Early registration deadline
Conferences, Workshops, CPD
Research Review Publications
Please login below to download this issue (PDF)